Skip to main content
logo
ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
17.68
+0.35 (1.99%)
At close: Oct 8, 2026, 4:00 PM EDT
17.41
-0.27 (-1.50%)
After-hours: Oct 8, 2026, 7:30 PM EDT

ADARx Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
58.4866.5214.03
Short-Term Investments
368.77413.48205.44
Cash & Short-Term Investments
427.25480219.48
Cash Growth
-118.70%-
Prepaid Expenses
14.2913.386.19
Total Current Assets
441.54493.38225.67
Property, Plant & Equipment
10.9812.077.13
Other Long-Term Assets
3.812.210.66
Total Assets
456.33507.66233.45

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
4.865.841.35
Accrued Expenses
8.536.376.8
Current Portion of Leases
1.711.710.79
Current Unearned Revenue
18.9116.56-
Total Current Liabilities
34.0130.498.94
Long-Term Leases
5.196.033.54
Long-Term Unearned Revenue
309.76314.99-
Other Long-Term Liabilities
0.810.780.51
Total Liabilities
349.76352.2912.98

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Additional Paid-In Capital
18.8616.4910.13
Retained Earnings
-269.13-220.7-147.61
Comprehensive Income & Other
-0.781.960.34
Total Common Equity
-251.05-202.26-137.15
Shareholders' Equity
106.57155.37220.48
Total Liabilities & Equity
456.33507.66233.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
6.97.744.33
Net Cash (Debt)
420.35472.26215.15
Net Cash Growth
-119.50%-
Net Cash Per Share
37.0341.5619.57
Filing Date Shares Outstanding
106.5811.3211
Total Common Shares Outstanding
11.3311.3211
Working Capital
407.53462.89216.73
Book Value Per Share
-22.16-17.87-12.47
Tangible Book Value
-251.05-202.26-137.15
Tangible Book Value Per Share
-22.16-17.87-12.47
Machinery
8.257.895.03
Construction In Progress
0.020.030.29
Leasehold Improvements
0.360.360.19
SEC Filings: 10-K · 10-Q